Medications

Second Interim Analysis of Clinical Trial Data Showed a 91.4% Efficacy for the Sputnik V Vaccine on Day 28 After the First Dose; Vaccine Efficacy is Over 95% 42 days After the First Dose

The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). Calculation was based on the analysis of data on volunteers (n = 18,794) who received both the first and second doses of the Sputnik […]

Health Problems

Clinical trial to evaluate sepsis treatment in children

Sepsis – a life-threatening inflammatory condition triggered by the body’s massive response to an infection – is diagnosed in about 75,000 children in the U.S. each year and causes about 7,000 deaths. The condition can escalate so rapidly that national guidelines recommend treatment begin within 20 minutes of a patient’s arrival to the emergency department. […]

Health News

AI isn't magic

When it comes to artificial intelligence healthcare solutions, it’s important to manage expectations for consumers and users. “The first thing that’s important to realise is that AI isn’t magic,” said David Champeaux, chief growth officer, Cherish Health, during a panel at the HIMSS & Health 2.0 Europe Digital Conference. Though AI can improve people’s lives, said […]

Health News

Virtual HIMSS & Health 2.0: Panel discusses Managing clinical variation in a new uncharted reality

Digital transformation within healthcare has accelerated in response to the pandemic, with rapid medical and healthcare delivery change. The panel discussion, ‘Managing Clinical Variation in a new unchartered reality’, is available to attendees on demand during the HIMSS & Health 2.0 European Digital Conference and explores how healthcare systems can enable consistent care by reducing variation […]

Health News

Clinical trial begins for new COVID-19 treatment

The University of Rochester Medical Center (URMC) is participating in a NIH-sponsored clinical trial to evaluate the safety and efficacy of the investigational antiviral drug remdesivir in hospitalized adults diagnosed with COVID-19. The study is being led by Ann R. Falsey, M.D., and Angela R. Branche, M.D., with the URMC Vaccine Trials and Evaluation Unit […]